Krystal Biotech, Inc. (KRYS)
KRYS price $322.74 -2.68 -0.82%
- Ticker
- KRYS
- Price
- $322.74
- Change
- -2.68 -0.82%
- Market cap
- $9.55B
- P/E
- 39.35
- Forward P/E
- 43.61
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 58
Krystal Biotech, Inc. is a clinical-stage biotechnology company focused on developing redosable gene therapies to address severe orphan diseases across the United States. Its most advanced therapeutic candidate, beremagene geperpavec (B-VEC), is currently undergoing Phase III clinical evaluation for the treatment of dystrophic epidermolysis bullosa. The company's pipeline also includes several other promising…